TrialFrontiers in cellular and infection microbiology2022

Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.

Dafa Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.